I'm no longer attempting fortune telling NZT.
However we appear to be closer than ever, with updates due that could provide more stock liquidity, due to being closer to proof of commercial potential:
1. Phase 2b dog trial - endpoints reached
2. Decision announced on phase 3 dog trial, possibly with licensing partner
3. Epichem / Shell update
4. MND cohort data assessed and market updated
Whether this occurs in the December or March quarter, or even later, I can't forecast! I hope all 4 updates are available sooner rather than later, which may enable you to sell your holding and may even put the oppies in the money. Will have to wait and see, frustrating as it is!
The big one would be the announcement of phase 2 human cancer trial proceeding, that would seem a longer wait! At these prices I may buy more.
DYOR
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1433
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.5¢ | $194.1K | 889.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4996 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 114999 | 4 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |